findmyKOL

Ann Bass, MD

Basic profile

Urology San Antonio

ORCIDNone on fileNPI
RegionSan Antonio, TX · South CentralSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ann Bass is a Neurology physician affiliated with Urology San Antonio. OpenAlex indexes 45 publications with 2,033 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
45publications

Distinct works indexed by OpenAlex.

2,033citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
125companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

125 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

125 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    69.9%
    Gabapentinoids10.3%
    Gabapentin54%Pregabalin41%Gralise5%
    Part D<11 patients
    Benzodiazepine7.3%
    Alprazolam48%Clonazepam31%Temazepam13%Lorazepam8%
    Part D<11 patients

    + 24 more classes in this area

  • Cancer & immunology

    11.3%
    Pyrimidine Synthesis Inhibitor3.3%
    Aubagio79%Teriflunomide21%
    Part D<11 patients
    Other immunosuppressants3.1%
    Dimethyl Fumarate53%Tecfidera33%Vumerity15%
    Part D<11 patients

    + 5 more classes in this area

  • Musculoskeletal

    7.9%
    gamma-Aminobutyric Acid-ergic Agonist3.6%
    Baclofen100%
    Part D33 patients
    Central alpha-2 Adrenergic Agonist3.5%
    Tizanidine Hcl100%
    Part D22 patients

    + 1 more class in this area

Where care is delivered (Part B)6.5% facility · 93.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”